Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by region (country), players, b ... Read More
1 Study Coverage 1.1 NSAID API Product Introduction 1.2 Global NSAID API Outlook 2017 VS 2022 VS 2028 1.2.1 Global NSAID API Sales in US$ Million for the Year 2017-2028 1.2.2 Global NSAID API Sales in Volume for the Year 2017-2028 1.3 United States NSAID API Outlook 2017 VS 2022 VS 2028 1.3.1 United States NSAID API Sales in US$ Million for the Year 2017-2028 1.3.2 United States NSAID API Sales in Volume for the Year 2017-2028 1.4 NSAID API Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States NSAID API in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of NSAID API Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 NSAID API Market Dynamics 1.5.1 NSAID API Industry Trends 1.5.2 NSAID API Market Drivers 1.5.3 NSAID API Market Challenges 1.5.4 NSAID API Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 NSAID API Market Segment by Type 2.1.1 Paracetamol 2.1.2 Ibuprofen 2.1.3 Aspirin 2.1.4 Naproxen 2.1.5 Others 2.2 Global NSAID API Market Size by Type 2.2.1 Global NSAID API Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global NSAID API Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global NSAID API Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States NSAID API Market Size by Type 2.3.1 United States NSAID API Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States NSAID API Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States NSAID API Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 NSAID API Market Segment by Application 3.1.1 Captive Manufacturing 3.1.2 Contract Manufacturing 3.2 Global NSAID API Market Size by Application 3.2.1 Global NSAID API Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global NSAID API Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global NSAID API Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States NSAID API Market Size by Application 3.3.1 United States NSAID API Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States NSAID API Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States NSAID API Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global NSAID API Competitor Landscape by Company 4.1 Global NSAID API Market Size by Company 4.1.1 Top Global NSAID API Manufacturers Ranked by Revenue (2021) 4.1.2 Global NSAID API Revenue by Manufacturer (2017-2022) 4.1.3 Global NSAID API Sales by Manufacturer (2017-2022) 4.1.4 Global NSAID API Price by Manufacturer (2017-2022) 4.2 Global NSAID API Concentration Ratio (CR) 4.2.1 NSAID API Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of NSAID API in 2021 4.2.3 Global NSAID API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global NSAID API Manufacturing Base Distribution, Product Type 4.3.1 Global NSAID API Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers NSAID API Product Type 4.3.3 Date of International Manufacturers Enter into NSAID API Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States NSAID API Market Size by Company 4.5.1 Top NSAID API Players in United States, Ranked by Revenue (2021) 4.5.2 United States NSAID API Revenue by Players (2020, 2021 & 2022) 4.5.3 United States NSAID API Sales by Players (2020, 2021 & 2022) 5 Global NSAID API Market Size by Region 5.1 Global NSAID API Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global NSAID API Market Size in Volume by Region (2017-2028) 5.2.1 Global NSAID API Sales in Volume by Region: 2017-2022 5.2.2 Global NSAID API Sales in Volume Forecast by Region (2023-2028) 5.3 Global NSAID API Market Size in Value by Region (2017-2028) 5.3.1 Global NSAID API Sales in Value by Region: 2017-2022 5.3.2 Global NSAID API Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America NSAID API Market Size YoY Growth 2017-2028 6.1.2 North America NSAID API Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific NSAID API Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific NSAID API Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe NSAID API Market Size YoY Growth 2017-2028 6.3.2 Europe NSAID API Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America NSAID API Market Size YoY Growth 2017-2028 6.4.2 Latin America NSAID API Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa NSAID API Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa NSAID API Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Novartis 7.1.1 Novartis Corporation Information 7.1.2 Novartis Description and Business Overview 7.1.3 Novartis NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Novartis NSAID API Products Offered 7.1.5 Novartis Recent Development 7.2 Pfizer 7.2.1 Pfizer Corporation Information 7.2.2 Pfizer Description and Business Overview 7.2.3 Pfizer NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Pfizer NSAID API Products Offered 7.2.5 Pfizer Recent Development 7.3 Boehringer Ingelheim 7.3.1 Boehringer Ingelheim Corporation Information 7.3.2 Boehringer Ingelheim Description and Business Overview 7.3.3 Boehringer Ingelheim NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Boehringer Ingelheim NSAID API Products Offered 7.3.5 Boehringer Ingelheim Recent Development 7.4 Teva Pharmaceutical 7.4.1 Teva Pharmaceutical Corporation Information 7.4.2 Teva Pharmaceutical Description and Business Overview 7.4.3 Teva Pharmaceutical NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Teva Pharmaceutical NSAID API Products Offered 7.4.5 Teva Pharmaceutical Recent Development 7.5 BASF 7.5.1 BASF Corporation Information 7.5.2 BASF Description and Business Overview 7.5.3 BASF NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.5.4 BASF NSAID API Products Offered 7.5.5 BASF Recent Development 7.6 Hospira 7.6.1 Hospira Corporation Information 7.6.2 Hospira Description and Business Overview 7.6.3 Hospira NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Hospira NSAID API Products Offered 7.6.5 Hospira Recent Development 7.7 Lonza Group 7.7.1 Lonza Group Corporation Information 7.7.2 Lonza Group Description and Business Overview 7.7.3 Lonza Group NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Lonza Group NSAID API Products Offered 7.7.5 Lonza Group Recent Development 7.8 Mylan 7.8.1 Mylan Corporation Information 7.8.2 Mylan Description and Business Overview 7.8.3 Mylan NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Mylan NSAID API Products Offered 7.8.5 Mylan Recent Development 7.9 Aurobindo Pharma 7.9.1 Aurobindo Pharma Corporation Information 7.9.2 Aurobindo Pharma Description and Business Overview 7.9.3 Aurobindo Pharma NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Aurobindo Pharma NSAID API Products Offered 7.9.5 Aurobindo Pharma Recent Development 7.10 Cambrex 7.10.1 Cambrex Corporation Information 7.10.2 Cambrex Description and Business Overview 7.10.3 Cambrex NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Cambrex NSAID API Products Offered 7.10.5 Cambrex Recent Development 7.11 Dr. Reddy's Laboratories 7.11.1 Dr. Reddy's Laboratories Corporation Information 7.11.2 Dr. Reddy's Laboratories Description and Business Overview 7.11.3 Dr. Reddy's Laboratories NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Dr. Reddy's Laboratories NSAID API Products Offered 7.11.5 Dr. Reddy's Laboratories Recent Development 7.12 Actavis 7.12.1 Actavis Corporation Information 7.12.2 Actavis Description and Business Overview 7.12.3 Actavis NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Actavis Products Offered 7.12.5 Actavis Recent Development 7.13 Wuxi Apptec 7.13.1 Wuxi Apptec Corporation Information 7.13.2 Wuxi Apptec Description and Business Overview 7.13.3 Wuxi Apptec NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.13.4 Wuxi Apptec Products Offered 7.13.5 Wuxi Apptec Recent Development 7.14 Zhejiang NHU 7.14.1 Zhejiang NHU Corporation Information 7.14.2 Zhejiang NHU Description and Business Overview 7.14.3 Zhejiang NHU NSAID API Sales, Revenue and Gross Margin (2017-2022) 7.14.4 Zhejiang NHU Products Offered 7.14.5 Zhejiang NHU Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 NSAID API Industry Chain Analysis 8.2 NSAID API Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 NSAID API Distributors 8.3 NSAID API Production Mode & Process 8.4 NSAID API Sales and Marketing 8.4.1 NSAID API Sales Channels 8.4.2 NSAID API Distributors 8.5 NSAID API Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
List of Tables Table 1. NSAID API CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. NSAID API Market Trends Table 3. NSAID API Market Drivers Table 4. NSAID API Market Challenges Table 5. NSAID API Market Restraints Table 6. Global NSAID API Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States NSAID API Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global NSAID API Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States NSAID API Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top NSAID API Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global NSAID API Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global NSAID API Revenue Share by Manufacturer, 2017-2022 Table 13. Global NSAID API Sales by Manufacturer, (K MT), 2017-2022 Table 14. Global NSAID API Sales Share by Manufacturer, 2017-2022 Table 15. Global NSAID API Price by Manufacturer (2017-2022) & (USD/MT) Table 16. Global NSAID API Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global NSAID API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAID API as of 2021) Table 18. Top Players of NSAID API in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers NSAID API Product Type Table 20. Date of International Manufacturers Enter into NSAID API Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top NSAID API Players in United States Market, Ranking by Revenue (2021) Table 23. United States NSAID API Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States NSAID API Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States NSAID API Sales by Players, (K MT), 2020, 2021 & 2022 Table 26. United States NSAID API Sales Share by Players, 2020, 2021 & 2022 Table 27. Global NSAID API Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global NSAID API Sales in Volume by Region (2017-2022) & (K MT) Table 29. Global NSAID API Sales in Volume Forecast by Region (2023-2028) & (K MT) Table 30. Global NSAID API Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global NSAID API Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America NSAID API Sales in Volume by Country (2017-2028) & (K MT) Table 33. North America NSAID API Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific NSAID API Sales in Volume by Region (2017-2028) & (K MT) Table 35. Asia Pacific NSAID API Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe NSAID API Sales in Volume by Country (2017-2028) & (K MT) Table 37. Europe NSAID API Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America NSAID API Sales in Volume by Country (2017-2028) & (K MT) Table 39. Latin Americaa NSAID API Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa NSAID API Sales in Volume by Country (2017-2028) & (K MT) Table 41. Middle East and Africa NSAID API Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Novartis Corporation Information Table 43. Novartis Description and Business Overview Table 44. Novartis NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 45. Novartis NSAID API Product Table 46. Novartis Recent Development Table 47. Pfizer Corporation Information Table 48. Pfizer Description and Business Overview Table 49. Pfizer NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 50. Pfizer Product Table 51. Pfizer Recent Development Table 52. Boehringer Ingelheim Corporation Information Table 53. Boehringer Ingelheim Description and Business Overview Table 54. Boehringer Ingelheim NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 55. Boehringer Ingelheim Product Table 56. Boehringer Ingelheim Recent Development Table 57. Teva Pharmaceutical Corporation Information Table 58. Teva Pharmaceutical Description and Business Overview Table 59. Teva Pharmaceutical NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 60. Teva Pharmaceutical Product Table 61. Teva Pharmaceutical Recent Development Table 62. BASF Corporation Information Table 63. BASF Description and Business Overview Table 64. BASF NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 65. BASF Product Table 66. BASF Recent Development Table 67. Hospira Corporation Information Table 68. Hospira Description and Business Overview Table 69. Hospira NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 70. Hospira Product Table 71. Hospira Recent Development Table 72. Lonza Group Corporation Information Table 73. Lonza Group Description and Business Overview Table 74. Lonza Group NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 75. Lonza Group Product Table 76. Lonza Group Recent Development Table 77. Mylan Corporation Information Table 78. Mylan Description and Business Overview Table 79. Mylan NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 80. Mylan Product Table 81. Mylan Recent Development Table 82. Aurobindo Pharma Corporation Information Table 83. Aurobindo Pharma Description and Business Overview Table 84. Aurobindo Pharma NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 85. Aurobindo Pharma Product Table 86. Aurobindo Pharma Recent Development Table 87. Cambrex Corporation Information Table 88. Cambrex Description and Business Overview Table 89. Cambrex NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 90. Cambrex Product Table 91. Cambrex Recent Development Table 92. Dr. Reddy's Laboratories Corporation Information Table 93. Dr. Reddy's Laboratories Description and Business Overview Table 94. Dr. Reddy's Laboratories NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 95. Dr. Reddy's Laboratories Product Table 96. Dr. Reddy's Laboratories Recent Development Table 97. Actavis Corporation Information Table 98. Actavis Description and Business Overview Table 99. Actavis NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 100. Actavis Product Table 101. Actavis Recent Development Table 102. Wuxi Apptec Corporation Information Table 103. Wuxi Apptec Description and Business Overview Table 104. Wuxi Apptec NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 105. Wuxi Apptec Product Table 106. Wuxi Apptec Recent Development Table 107. Zhejiang NHU Corporation Information Table 108. Zhejiang NHU Description and Business Overview Table 109. Zhejiang NHU NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 110. Zhejiang NHU Product Table 111. Zhejiang NHU Recent Development Table 112. Key Raw Materials Lists Table 113. Raw Materials Key Suppliers Lists Table 114. NSAID API Customers List Table 115. NSAID API Distributors List Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. NSAID API Product Picture Figure 2. Global NSAID API Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global NSAID API Market Size 2017-2028 (US$ Million) Figure 4. Global NSAID API Sales 2017-2028 (K MT) Figure 5. United States NSAID API Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States NSAID API Market Size 2017-2028 (US$ Million) Figure 7. United States NSAID API Sales 2017-2028 (K MT) Figure 8. United States NSAID API Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States NSAID API Market Share in Global, in Volume (K MT) 2017-2028 Figure 10. NSAID API Report Years Considered Figure 11. Product Picture of Paracetamol Figure 12. Product Picture of Ibuprofen Figure 13. Product Picture of Aspirin Figure 14. Product Picture of Naproxen Figure 15. Product Picture of Others Figure 16. Global NSAID API Market Share by Type in 2022 & 2028 Figure 17. Global NSAID API Sales in Value by Type (2017-2028) & (US$ Million) Figure 18. Global NSAID API Sales Market Share in Value by Type (2017-2028) Figure 19. Global NSAID API Sales by Type (2017-2028) & (K MT) Figure 20. Global NSAID API Sales Market Share in Volume by Type (2017-2028) Figure 21. Global NSAID API Price by Type (2017-2028) & (USD/MT) Figure 22. United States NSAID API Market Share by Type in 2022 & 2028 Figure 23. United States NSAID API Sales in Value by Type (2017-2028) & (US$ Million) Figure 24. United States NSAID API Sales Market Share in Value by Type (2017-2028) Figure 25. United States NSAID API Sales by Type (2017-2028) & (K MT) Figure 26. United States NSAID API Sales Market Share in Volume by Type (2017-2028) Figure 27. United States NSAID API Price by Type (2017-2028) & (USD/MT) Figure 28. Product Picture of Captive Manufacturing Figure 29. Product Picture of Contract Manufacturing Figure 30. Global NSAID API Market Share by Application in 2022 & 2028 Figure 31. Global NSAID API Sales in Value by Application (2017-2028) & (US$ Million) Figure 32. Global NSAID API Sales Market Share in Value by Application (2017-2028) Figure 33. Global NSAID API Sales by Application (2017-2028) & (K MT) Figure 34. Global NSAID API Sales Market Share in Volume by Application (2017-2028) Figure 35. Global NSAID API Price by Application (2017-2028) & (USD/MT) Figure 36. United States NSAID API Market Share by Application in 2022 & 2028 Figure 37. United States NSAID API Sales in Value by Application (2017-2028) & (US$ Million) Figure 38. United States NSAID API Sales Market Share in Value by Application (2017-2028) Figure 39. United States NSAID API Sales by Application (2017-2028) & (K MT) Figure 40. United States NSAID API Sales Market Share in Volume by Application (2017-2028) Figure 41. United States NSAID API Price by Application (2017-2028) & (USD/MT) Figure 42. North America NSAID API Sales in Volume Growth Rate 2017-2028 (K MT) Figure 43. North America NSAID API Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 44. U.S. NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Canada NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. Europe NSAID API Sales in Volume Growth Rate 2017-2028 (K MT) Figure 47. Europe NSAID API Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 48. Germany NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. France NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. U.K. NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Italy NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Russia NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Asia-Pacific NSAID API Sales in Volume Growth Rate 2017-2028 (K MT) Figure 54. Asia-Pacific NSAID API Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 55. China NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Japan NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. South Korea NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. India NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Australia NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Taiwan NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Indonesia NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Thailand NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Malaysia NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Philippines NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Latin America NSAID API Sales in Volume Growth Rate 2017-2028 (K MT) Figure 66. Latin America NSAID API Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 67. Mexico NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Brazil NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Argentina NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Middle East & Africa NSAID API Sales in Volume Growth Rate 2017-2028 (K MT) Figure 71. Middle East & Africa NSAID API Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 72. Turkey NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Saudi Arabia NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. UAE NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 75. NSAID API Value Chain Figure 76. NSAID API Production Process Figure 77. Channels of Distribution Figure 78. Distributors Profiles Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed
Novartis Pfizer Boehringer Ingelheim Teva Pharmaceutical BASF Hospira Lonza Group Mylan Aurobindo Pharma Cambrex Dr. Reddy's Laboratories Actavis Wuxi Apptec Zhejiang NHU
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by region (country), players, b ... Read More
Nuclear Cardiology market is segmented by region (country), players, by Type and by Application. ... Read More
Nuclear Magnetic Resonance (NMR) Spectrometers market is segmented by region (country), players, ... Read More
NMR Spectrometers market is segmented by region (country), players, by Type and by Application. P ... Read More